Michelle Denburg, MD, MSCE
Michelle Denburg, MD, MSCE is a core faculty member at the Center for Pediatric Clinical Effectiveness (CPCE) at the Children's Hospital of Philadelphia (CHOP), Division of Nephrology and the Cancer Survivorship Program at CHOP, and an assistant professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania. She holds a bachelor's degree from Yale University, received her MD from Cornell University, and is board certified in pediatric nephrology. She completed a residency in pediatrics at New York-Presbyterian Morgan Stanley Children’s Hospital and from 2007-2010 she completed a pediatric nephrology fellowship at CHOP and earned her Masters of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania.
Dr. Denburg’s research is focused on complications of childhood kidney diseases, including chronic kidney disease (CKD), glomerular disease, and urinary stone disease, with a particular interest in bone health and altered mineral metabolism. She is the Associate Director for the recently funded CHOP Pediatric Center of Excellence in Nephrology and as co-PI of a CKD Biomarkers Consortium project to identify novel biomarkers for CKD progression in children. She is also Principal Investigator of an ancillary study to the Nephrotic Syndrome Study Network (NEPTUNE) to relate baseline measures of vitamin D-related mineral metabolism to tubulointerstitial injury and a pilot trial of vitamin D supplementation in patients with glomerular disease.
Through her work, Dr. Denburg aims to address fundamental limitations in our understanding of skeletal morbidity in patients with CKD, glomerular disease, and urinary stone disease, and develop resources to efficiently conduct observational research and trials to optimize health outcomes in these high risk populations.
Contact Dr. Denburg at firstname.lastname@example.org.
To view Dr. Denburg's peer-reviewed publications, click here.